The author's proposal was based upon their results showing that by inhibiting DDR1, the changes in brain tissue seen in Parkinson's diseases such as inflammation, neuronal injury, autophagy and vesicular transport are reversed. The gene discussed is DDR1; the disease is Parkinson disease.